COVID-19 patients coexisting with diabetes, hypertension, or neoplasia had significantly higher levels of IL-6 and IFN-γ from the early stage of infection—usually accompanied by decreased lymphocytes—and were prone to organ and coagulation disorders. This evidence concerns the gene IL6 and neoplasm.